Xiaorong Hou

1.6k total citations
86 papers, 909 citations indexed

About

Xiaorong Hou is a scholar working on Obstetrics and Gynecology, Surgery and Epidemiology. According to data from OpenAlex, Xiaorong Hou has authored 86 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Obstetrics and Gynecology, 23 papers in Surgery and 21 papers in Epidemiology. Recurrent topics in Xiaorong Hou's work include Endometrial and Cervical Cancer Treatments (35 papers), Ovarian cancer diagnosis and treatment (17 papers) and Cervical Cancer and HPV Research (16 papers). Xiaorong Hou is often cited by papers focused on Endometrial and Cervical Cancer Treatments (35 papers), Ovarian cancer diagnosis and treatment (17 papers) and Cervical Cancer and HPV Research (16 papers). Xiaorong Hou collaborates with scholars based in China, United States and United Kingdom. Xiaorong Hou's co-authors include Fuquan Zhang, Ke Hu, Weiping Wang, Junfang Yan, Xin Lian, Zhikai Liu, Shuai Sun, Jie Shen, Barbara L. Gaffney and Roger A. Jones and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Xiaorong Hou

76 papers receiving 902 citations

Peers

Xiaorong Hou
Fabio Cappuccini United States
Scott A. Gerber United States
Sanjay Logani United States
S. Markaki Greece
Camillus Chua Singapore
Fabio Cappuccini United States
Xiaorong Hou
Citations per year, relative to Xiaorong Hou Xiaorong Hou (= 1×) peers Fabio Cappuccini

Countries citing papers authored by Xiaorong Hou

Since Specialization
Citations

This map shows the geographic impact of Xiaorong Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaorong Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaorong Hou more than expected).

Fields of papers citing papers by Xiaorong Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaorong Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaorong Hou. The network helps show where Xiaorong Hou may publish in the future.

Co-authorship network of co-authors of Xiaorong Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaorong Hou. A scholar is included among the top collaborators of Xiaorong Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaorong Hou. Xiaorong Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hou, Xiaorong, Yuping Zhao, Yuhui Li, et al.. (2025). The structural discrepancy in the immunomodulatory potency of the polysaccharides RFHP-1 and RFHP-2 derived from Radix Fici Hirtae. International Journal of Biological Macromolecules. 315(Pt 1). 144432–144432.
2.
Hou, Xiaorong, Jing Shen, Hui Guan, et al.. (2025). A deep learning model to predict dose distributions for breast cancer radiotherapy. Discover Oncology. 16(1). 165–165.
3.
Shen, Jing, Kun Zhang, Bo Yang, et al.. (2025). Deep Inspiratory Breath-Hold Technique for Patients with Left-Sided Breast Cancer: Dosimetric Analysis, Clinical Evaluation, and Prediction. Technology in Cancer Research & Treatment. 24. 2244071008–2244071008.
4.
Hu, Ke, et al.. (2024). Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy. Journal of Gynecologic Oncology. 35(6). e84–e84. 1 indexed citations
5.
6.
Wang, Yunchao, Xiaobo Yang, Yanyu Wang, et al.. (2023). Effectiveness and safety of radiotherapy plus programmed death-1 inhibitors and lenvatinib in patients with advanced biliary tract carcinoma: a real-world study. Cancer Immunology Immunotherapy. 72(7). 2197–2204. 5 indexed citations
7.
Guan, Hui, Guangyu Wang, Weiping Wang, et al.. (2023). Postoperative adjuvant radiotherapy for patients with upper tract urothelial carcinoma (UTUC) who underwent kidney-sparing surgery (KSS): a single-center study. Radiation Oncology. 18(1). 120–120. 2 indexed citations
8.
Wu, Hong-Fen, et al.. (2023). Dose-Volume Predictors for Radiation Esophagitis in Breast Cancer Patients Undergoing Hypofractionated Regional Nodal Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 117(2). e211–e212.
9.
Hu, Ke, et al.. (2023). Investigation of standardized training of radiation oncology residents for gynaecological tumours in China. BMC Medical Education. 23(1). 296–296. 1 indexed citations
10.
Wang, Tiejun, Zi Liu, Jianli He, et al.. (2023). Practice patterns of adjuvant radiotherapy in women with stage I to II endometrial carcinoma: a real-world multi-institutional analysis in China. BMC Women s Health. 23(1). 417–417. 1 indexed citations
11.
Hao, Jing, Na Zhang, Yahua Zhong, et al.. (2022). Variability of Target Volumes and Organs at Risk Delineation in Breast Cancer Radiation Therapy: Quality Assurance Results of the Pretrial Benchmark Case for the POTENTIAL Trial. Practical Radiation Oncology. 12(5). 397–408. 5 indexed citations
12.
Liu, Zhen, Mengli Wang, Jie Ni, et al.. (2021). Mutation spectrum of amyotrophic lateral sclerosis in Central South China. Neurobiology of Aging. 107. 181–188. 20 indexed citations
13.
Zhao, Guihu, Zhen Liu, Mengli Wang, et al.. (2021). Gene4MND: An Integrative Genetic Database and Analytic Platform for Motor Neuron Disease. Frontiers in Molecular Neuroscience. 14. 644202–644202.
15.
Wang, Weiping, Xiaorong Hou, Junfang Yan, et al.. (2017). Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women. BMC Cancer. 17(1). 510–510. 55 indexed citations
16.
Sun, Shuai, Fuquan Zhang, Ke Hu, et al.. (2013). Clinical effect of concurrent chemotherapy and intensity-modulated radiotherapy in postoperative cervical cancer patients. Zhonghua fangshe zhongliuxue zazhi. 22(1). 13–16. 1 indexed citations
17.
Qiu, Jie, Zhikai Liu, Bo Yang, Xiaorong Hou, & Fuquan Zhang. (2013). Low-Dose-Area-Constrained Helical TomoTherapy-Based Whole Breast Radiotherapy and Dosimetric Comparison with Tangential Field-in-Field IMRT. BioMed Research International. 2013. 1–6. 12 indexed citations
18.
Hu, Ke, Wenbo Li, Xiaorong Hou, et al.. (2011). The efficacy of neoadjuvant concurrent chemoradiotherapy or radiotherapy alone in patients with locally advanced rectal cancer. Zhonghua fangshe zhongliuxue zazhi. 20(6). 502–505. 1 indexed citations
19.
Das, Kalyan, Rajiv P. Bandwar, Kirsten White, et al.. (2009). Structural Basis for the Role of the K65R Mutation in HIV-1 Reverse Transcriptase Polymerization, Excision Antagonism, and Tenofovir Resistance. Journal of Biological Chemistry. 284(50). 35092–35100. 71 indexed citations
20.
Shen, Jie, Fuquan Zhang, Ke Hu, et al.. (2009). Outcome of three-dimensional conformal radiotherapy for 109 patients with bladder cancer. Zhonghua fangshe zhongliuxue zazhi. 18(2). 115–119. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026